We are live on ! Find out more
SRNE

Sorrento Therapeutics, Inc.
SRNE

Delisted

SRNE was delisted on the 22nd of February, 2023.

Back to rankings

5 hedge funds and large institutions have $70 invested in Sorrento Therapeutics, Inc. in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

82% less capital invested

Capital invested by funds: $380 → $70 (-$310)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

SRNE Hedge Fund Activity: Q2 2026 in Review

5 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q2 2026, worth a combined $70 — down 82% from $380 a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new SRNE positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

  • 5 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q2 2026, up from 4 in Q1 2026.
  • Funds reported $70 of Sorrento Therapeutics, Inc. stock for Q2 2026, down 82% quarter-over-quarter.
  • 2 funds opened new Sorrento Therapeutics, Inc. positions in Q2 2026 and 0 closed out, a net change of +2 holders.

Based on aggregated 13F filings for Q2 2026.